The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 30, 2018
Filed:
Jun. 02, 2016
Applicant:
Sanofi, Paris, FR;
Inventors:
Nicolas Baurin, Arpajon, FR;
Francis Blanche, Paris, FR;
Beatrice Cameron, Paris, FR;
Marc Duchesne, Sucy en Brie, FR;
Vincent Mikol, Charenton-le-Pont, FR;
Souad Naimi, Sain Maur des Fosses, FR;
Laurent Pradier, Verrieres, FR;
Yi Shi, Paris, FR;
Assignee:
SANOFI, Paris, FR;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); C07H 21/04 (2006.01); A61K 39/395 (2006.01); C12N 15/63 (2006.01); C12N 15/85 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 39/3955 (2013.01); C07H 21/04 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/52 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/71 (2013.01); C07K 2317/92 (2013.01); C12N 15/63 (2013.01); C12N 2015/8518 (2013.01);
Abstract
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide are provided. Methods of using antibodies specific to the protofibrillar form of the beta-amyloid peptide in the field of Alzheimer's disease are also provided.